Accelerated Theta Burst Stimulation: Safety, Efficacy, and Future Advancements.

Accelerated theta burst stimulation Brain stimulation Efficacy MDD Major depressive disorder Review TBS Theta burst stimulation aTBS

Journal

Biological psychiatry
ISSN: 1873-2402
Titre abrégé: Biol Psychiatry
Pays: United States
ID NLM: 0213264

Informations de publication

Date de publication:
15 Mar 2024
Historique:
received: 01 07 2023
revised: 05 12 2023
accepted: 08 12 2023
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 21 2 2024
Statut: ppublish

Résumé

Theta burst stimulation (TBS) is a noninvasive brain stimulation technique that can be used to modulate neural networks underlying psychiatric and neurological disorders. TBS can be delivered intermittently or continuously. The conventional intermittent TBS protocol is approved by the U.S. Food and Drug Administration to treat otherwise treatment-resistant depression, but the 6-week duration limits the applicability of this therapy. Accelerated TBS protocols present an opportunity to deliver higher pulse doses in shorter periods of time, thus resulting in faster and potentially more clinically effective treatment. However, the acceleration of TBS delivery raises questions regarding the relative safety, efficacy, and durability compared with conventional TBS protocols. In this review paper, we present the data from accelerated TBS trials to date that support the safety and effectiveness of accelerated protocols while acknowledging the need for more durability data. We discuss the stimulation parameters that seem to be important for the efficacy of accelerated TBS protocols and possible avenues for further optimization.

Identifiants

pubmed: 38383091
pii: S0006-3223(23)01761-4
doi: 10.1016/j.biopsych.2023.12.004
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

523-535

Informations de copyright

Copyright © 2023 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Eleanor Cole (E)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California.

Sean J O'Sullivan (SJ)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California; Department of Psychiatry and Behavioral Sciences, Dell School of Medicine, Austin, Texas.

Martin Tik (M)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California; Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria.

Nolan R Williams (NR)

Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, California. Electronic address: nolanw@stanford.edu.

Classifications MeSH